Jonathan M. Loree

The University of British Columbia

Canada

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Epidemiology

60%

Biostatistics

30%

Oncology

70%

Cancer Biology

40%

Colorectal Cancer

40%

Cancer Epidemiology

30%

Covid-19

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis

Article Link

Year:

2024

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Article Link

Year:

2022

Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns?

Article Link

Year:

2021

Hereditary and Inflammatory Bowel Disease-Related Early Onset Colorectal Cancer Have Unique Characteristics and Clinical Course Compared with Sporadic Disease

Article Link

Year:

2021

Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

Article Link

Year:

2021

Trends in the Incidence of Young-Onset Colorectal Cancer With a Focus on Years Approaching Screening Age: A Population-Based Longitudinal Study

Article Link

Year:

2021

Underreporting of race/ethnicity in COVID-19 research

Article Link

Year:

2021

Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors

Article Link

Year:

2021

FOLFOXIRI plus Bevacizumab Versus FOLFOX plus Panitumumab for Metastatic Left‐Sided RAS / BRAF Wild‐Type Colorectal Cancer: Which “Side” Are You On?

Article Link

Year:

2021

Virtual Oncology Appointments during the Initial Wave of the COVID-19 Pandemic: An International Survey of Patient Perspectives

Article Link

Year:

2021

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Article Link

Year:

2021

Collaborators4

Kangjin Jeong

Oregon Health & Science University

UNITED STATES

Ari VanderWalde

Global Head of Clinical Trials

UNITED STATES

Carl Brown

The University of British Columbia

CANADA

Mary A. De Vera

The University of British Columbia

CANADA

How do I reach out?

Meet Kite AI